Clinical Pearl: Inhaled Budesonide with Surfactant Decreases BPD Rates Without Affecting Neurodevelopmental Outcomes 

/

, , , , ,

Melanie Wielicka, MD, PhD, Joseph R Hageman, MD 

nt-21-08-132-133Download